e-learning
resources
European Respiratory Review
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Personalised medicine for cystic fibrosis: treating the basic defect
J. Stuart Elborn
Source:
Eur Respir Rev 2013; 22: 3-5
Journal Issue:
March 2013 - 22 (127)
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Stuart Elborn. Personalised medicine for cystic fibrosis: treating the basic defect. Eur Respir Rev 2013; 22: 3-5
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Is cystic fibrosis the hemi-neglected part of respiratory medicine?
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021
Advanced cell culture techniques and personalised medicine for cystic fibrosis
Source: International Congress 2015 – Respiratory research in the Netherlands
Year: 2015
A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021
Year: 2021
Re-imagining cystic fibrosis care: next generation thinking
Source: Eur Respir J, 55 (5) 1902443; 10.1183/13993003.02443-2019
Year: 2020
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis
Source: Eur Respir J, 51 (6) 1702457; 10.1183/13993003.02457-2017
Year: 2018
The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013
Genomically-guided therapies: a new era for cystic fibrosis
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020
Cystic fibrosis: prospects for therapy of some class 1 mutations
Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Year: 2007
Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020
The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
Source: Eur Respir J 2007; 29: 229-230
Year: 2007
Medical rehabilitation programme in cystic fibrosis
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009
Implementation of non-medical prescribing within the clinical cystic fibrosis setting
Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions
Year: 2014
Health-economic aspects of cystic fibrosis screening and therapy
Source: Eur Respir Monogr 2014; 64: 304-319
Year: 2014
Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
What’s new in cystic fibrosis?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept